Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q09435

Entry ID Method Resolution Chain Position Source
AF-Q09435-F1 Predicted AlphaFoldDB

No variants for Q09435

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q09435

No associated diseases with Q09435

6 regional properties for Q09435

Type Name Position InterPro Accession
domain Protein kinase domain 557 - 826 IPR000719
domain Adenylyl cyclase class-3/4/guanylyl cyclase 862 - 1077 IPR001054
domain Serine-threonine/tyrosine-protein kinase, catalytic domain 607 - 822 IPR001245
domain Receptor, ligand binding region 54 - 431 IPR001828
domain Haem NO binding associated 835 - 883 IPR011645
conserved_site Adenylyl cyclase class-4/guanylyl cyclase, conserved site 1005 - 1028 IPR018297

Functions

Description
EC Number 4.6.1.2 Phosphorus-oxygen lyases
Subcellular Localization
  • Membrane ; Single-pass type I membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

5 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
GTP binding Binding to GTP, guanosine triphosphate.
guanylate cyclase activity Catalysis of the reaction: GTP = 3',5'-cyclic GMP + diphosphate.
peptide receptor activity Combining with an extracellular or intracellular peptide to initiate a change in cell activity.
protein kinase activity Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.

10 GO annotations of biological process

Name Definition
cGMP biosynthetic process The chemical reactions and pathways resulting in the formation of cyclic GMP, guanosine 3',5'-phosphate.
chemosensory behavior Behavior that is dependent upon the sensation of chemicals.
chemotaxis The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
intracellular signal transduction The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
protein phosphorylation The process of introducing a phosphate group on to a protein.
receptor guanylyl cyclase signaling pathway The series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell where the receptor possesses guanylyl cyclase activity, and ending with the regulation of a downstream cellular process, e.g. transcription.
response to lithium ion Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus.
response to potassium ion Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a potassium ion stimulus.
response to salt Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a salt stimulus.
signal transduction The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

17 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P46197 NPR2 Atrial natriuretic peptide receptor 2 Bos taurus (Bovine) PR
O02740 GUCY2F Retinal guanylyl cyclase 2 Bos taurus (Bovine) PR
P51841 GUCY2F Retinal guanylyl cyclase 2 Homo sapiens (Human) PR
Q02846 GUCY2D Retinal guanylyl cyclase 1 Homo sapiens (Human) PR
P20594 NPR2 Atrial natriuretic peptide receptor 2 Homo sapiens (Human) PR
P52785 Gucy2e Retinal guanylyl cyclase 1 Mus musculus (Mouse) PR
Q6VVW5 Npr2 Atrial natriuretic peptide receptor 2 Mus musculus (Mouse) PR
Q5SDA5 Gucy2f Retinal guanylyl cyclase 2 Mus musculus (Mouse) PR
P51840 Gucy2e Retinal guanylyl cyclase 1 Rattus norvegicus (Rat) PR
P18910 Npr1 Atrial natriuretic peptide receptor 1 Rattus norvegicus (Rat) PR
P16067 Npr2 Atrial natriuretic peptide receptor 2 Rattus norvegicus (Rat) PR
P51842 Gucy2f Retinal guanylyl cyclase 2 Rattus norvegicus (Rat) PR
Q10029 gcy-2 Receptor-type guanylate cyclase gcy-2 Caenorhabditis elegans PR
Q18331 gcy-11 Receptor-type guanylate cyclase gcy-11 Caenorhabditis elegans PR
Q23682 gcy-5 Receptor-type guanylate cyclase gcy-5 Caenorhabditis elegans PR
O16544 gcy-19 Receptor-type guanylate cyclase gcy-19 Caenorhabditis elegans PR
X5M8U1 gcy-17 Receptor-type guanylate cyclase gcy-17 Caenorhabditis elegans PR
10 20 30 40 50 60
MQIFTILLLF NIFPSIFVQN LPDTTVAPRT KRTIKIGIAA AQRIQTSSIG WSVCGGAVPL
70 80 90 100 110 120
AIERLKEMGF VKDFDFEYIV DYTECDLGSV VRAGMEFIKT HKVDVIIGPP CAQALRLMSF
130 140 150 160 170 180
LAENYKKPVL GWGFVSDTDL SDVIRFPHLT TVIPNSLMLG YAASKMLTTF HWNRVALLYY
190 200 210 220 230 240
FSDVKYCSGV MNDIEATFND PSTPNVNIVI KAEIYLNDNE TTDNVFQTVK SRARIILWCT
250 260 270 280 290 300
QTSVEKRDYL IKIATHDMIG DEYVHIMLSM RNVAFGTQTS LGKPTFSQSG LTPIWESFTE
310 320 330 340 350 360
GTDGFEKMAK QAATRMFVLD VNSEVADKKY LEYMQKNIIK AVQSPPMNCS TVECMTANTT
370 380 390 400 410 420
IMGGYARHLF DVVYLYGIAL THTNSTDPAV YGDVDVLVHQ FVTSFQGMTG HVVISPNLTR
430 440 450 460 470 480
MPIFQLYGLN SDYDQVALVD FTYTNSVMVP NVTLFYKDEG GAVWSYYGHS RPLDIPICGF
490 500 510 520 530 540
LGKSCPVSFW EQYKILIFVA IAVIVLMVLI MIIGCLCVIS GKRAERARIN AEWQVPFAKL
550 560 570 580 590 600
IESEKQVRGK GASRRSLQSA PSISTGHSGV TTVSDFCENY TMMMYEKEMV LTAKYQYTHL
610 620 630 640 650 660
TKADKERFVK MRKLDHENIN RFIGLSIDSA HFISVTKLCS RGSLQDILSR GNFSMDYFFM
670 680 690 700 710 720
FCIIRDVAKG LEYLHKTFLR LHGNLRSATC LVNDSWQVKL AEYGMDNLVE EQTPPKKRLL
730 740 750 760 770 780
WVAPEVLRGS LSVSQMEPSA DIYSFAIIAS EILTKKEAWD ILDRKEDCEE IVYNVKKGGL
790 800 810 820 830 840
FPIRPEIITD IHDVNPALIA LVKDCWAEVP EDRPTAENIC SQMKGLVSKQ KTNLMDHVFN
850 860 870 880 890 900
MLEEYTSTLE EEIEERTKEL TLEKKKADIL LSRMLPKQVA ERLKAGQTVE PEGFDSVTVF
910 920 930 940 950 960
FSDVVKFTIL ASKCSPFQTV NLLNDLYSNF DTIIEQHGVY KVESIGDGYL CVSGLPTRNG
970 980 990 1000 1010 1020
YAHIKQIVDM SLKFMEYCKS FNIPHLPREN VELRIGVNSG PCVAGVVGLS MPRYCLFGDT
1030 1040 1050 1060 1070 1080
VNTASRMESN GKPSLIHLTN DAHSLLTTHY PNQYETSSRG EVIIKGKGVM ETFWVHGRFG
1090 1100 1110 1120 1130
EMEPTELRSI SNRSTPPVTN DRWIPNPSSS HGSRPSSVYD PLQGHQKFKM DTLKVAN